Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies
(Source: Abbott.com)
Source: Abbott.com - September 17, 2022 Category: Pharmaceuticals Source Type: news
Abbott Declares 395th Consecutive Quarterly Dividend
(Source: Abbott.com)
Source: Abbott.com - September 15, 2022 Category: Pharmaceuticals Source Type: news
Three-Year Data on World's Smallest Heart Device Show Benefits of Fixing Holes in Newborn Hearts Without Surgery
(Source: Abbott.com)
Source: Abbott.com - September 8, 2022 Category: Pharmaceuticals Source Type: news
Abbott Announces European Launch of Amplatzer ™ Talisman™ System to Close Hole in Heart for People at Risk of Recurrent Stroke
- Abbott's Talisman system seals an opening in the heart known as a "patent foramen ovale" (PFO) to prevent blood clots from passing from the right to the left side of the heart and on to the brain, where they can cause a stroke (Source: Abbott.com)
Source: Abbott.com - September 7, 2022 Category: Pharmaceuticals Source Type: news
New Data Show Abbott's HeartMate 3 ™ Heart Pump Extends Life Beyond Five Years for Advanced Heart Failure Patients
(Source: Abbott.com)
Source: Abbott.com - August 29, 2022 Category: Pharmaceuticals Source Type: news
FDA Approves Abbott's New Spinal Cord Stimulation Device; Provides Tailored Relief to Multiple Pain Areas and Adds More Treatment Options for Evolving Pain Conditions
(Source: Abbott.com)
Source: Abbott.com - August 23, 2022 Category: Pharmaceuticals Source Type: news
New Study Shows Abbott's Blood Test for Concussion Could Predict Outcomes from Brain Injury and Inform Treatment Interventions
(Source: Abbott.com)
Source: Abbott.com - August 11, 2022 Category: Pharmaceuticals Source Type: news
Abbott and WeightWatchers Partner to Support People Living with Diabetes in Attaining their Health Goals
(Source: Abbott.com)
Source: Abbott.com - August 4, 2022 Category: Pharmaceuticals Source Type: news
Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance
(Source: Abbott.com)
Source: Abbott.com - July 20, 2022 Category: Pharmaceuticals Source Type: news
Abbott Receives FDA's Breakthrough Device Designation to Explore Use of Deep Brain Stimulation to Manage Severe Depression
(Source: Abbott.com)
Source: Abbott.com - July 12, 2022 Category: Pharmaceuticals Source Type: news
Abbott Hosts Conference Call for Second-Quarter Earnings
(Source: Abbott.com)
Source: Abbott.com - June 29, 2022 Category: Pharmaceuticals Source Type: news
Easterseals and the Abbott Fund Join Together to Advance Education and Health Equity
(Source: Abbott.com)
Source: Abbott.com - June 22, 2022 Category: Pharmaceuticals Source Type: news
Abbott Declares 394th Consecutive Quarterly Dividend
(Source: Abbott.com)
Source: Abbott.com - June 10, 2022 Category: Pharmaceuticals Source Type: news
Late-Breaking Data Reinforce Broad Range of Patients Benefit from Abbott's Mitral and Tricuspid Heart Valve Devices
- New results demonstrate MitraClip ™ transcatheter edge-to-edge repair (TEER) is effective at treating leaky valves in people with secondary mitral regurgitation (MR) (Source: Abbott.com)
Source: Abbott.com - June 8, 2022 Category: Pharmaceuticals Source Type: news
Late-Breaking Data Demonstrate Abbott's FreeStyle Libre ® 3 System is Most Accurate 14-Day Continuous Glucose Monitor
(Source: Abbott.com)
Source: Abbott.com - June 5, 2022 Category: Pharmaceuticals Source Type: news
